argenx SE (EBR:ARGX)
714.80
+2.40 (0.34%)
Oct 29, 2025, 4:42 PM CET
argenx SE Market Cap
argenx SE has a market cap or net worth of €43.86 billion as of October 29, 2025. Its market cap has increased by 43.19% in one year.
Market Cap
43.86B
Enterprise Value
40.55B
Revenue
2.66B
Ranking
n/a
PE Ratio
44.89
Stock Price
€714.80
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 43.86B, an increase of 35,723.66%. That is a compound annual growth rate of 68.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 43.86B | 21.08% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | 11.40B | 85.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 46.21B |
| Financière de Tubize | 10.19B |
| Fagron NV | 1.53B |
| Ion Beam Applications | 323.69M |
| Onward Medical | 198.85M |
| Nyxoah | 180.63M |
| Hyloris Pharmaceuticals | 151.20M |
| Sequana Medical NV | 44.88M |